MCK - McKesson Corporation

NYSE - NYSE Delayed Price. Currency in USD
132.08
-3.12 (-2.31%)
At close: 4:02PM EDT

132.08 0.00 (0.00%)
After hours: 5:07PM EDT

Stock chart is not supported by your current browser
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
  • Short Term
    2W - 6W
  • Mid Term
    6W - 9M
  • Long Term
    9M+
Previous Close135.20
Open140.00
Bid125.10 x 1400
Ask145.49 x 800
Day's Range131.54 - 141.57
52 Week Range111.71 - 172.18
Volume1,676,598
Avg. Volume5,197,380
Market Cap21.331B
Beta (5Y Monthly)0.88
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield1.64 (1.31%)
Ex-Dividend DateFeb 27, 2020
1y Target EstN/A
  • Moody's

    McKesson Corporation -- Moody's announces completion of a periodic review of ratings of McKesson Corporation

    Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of McKesson Corporation and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers.

  • MCK vs. COO: Which Stock Is the Better Value Option?
    Zacks

    MCK vs. COO: Which Stock Is the Better Value Option?

    MCK vs. COO: Which Stock Is the Better Value Option?

  • Here's Why You Should Invest in McKesson (MCK) Stock Now
    Zacks

    Here's Why You Should Invest in McKesson (MCK) Stock Now

    McKesson (MCK) continues to gain traction from its multi-year strategic growth initiative and distribution solutions segment.

  • GuruFocus.com

    Wall Street Gains on Monday

    Cal-Maine Foods' third-quarter revenue declines Continue reading...

  • These indicators suggest a stock-market bottom, but coronavirus fears could send the S&P 500 swooning again
    MarketWatch

    These indicators suggest a stock-market bottom, but coronavirus fears could send the S&P 500 swooning again

    The question investors must now ask themselves is whether or not the market has already hit the bottom of this bear market, or whether investors should prepare themselves for worse to come.

  • Reuters

    White House-led airlift of urgently needed medical supplies arrives in New York

    A planeload of desperately needed medical supplies arrived in New York from China on Sunday, the first in a series of flights over the next 30 days organized by the White House to help fight the coronavirus, a White House official said. A commercial carrier landed at John F. Kennedy airport carrying gloves, gowns and masks for distribution in New York, New Jersey and Connecticut, three hard-hit states battling to care for a crush of coronavirus patients. The airlift is a product of a team led by White House senior adviser Jared Kushner, which formed "Project Airbridge," a partnership between large U.S. healthcare distributors such as McKesson Corp, Cardinal, Owens & Minor, Medline and Henry Schein Inc, and the federal government.

  • The Top Health Care Companies in the World
    Investopedia

    The Top Health Care Companies in the World

    Ranked by trailing 12-month sales as of March 2020, these are the largest health care companies globally.

  • Is McKesson (MCK) a Great Value Stock Right Now?
    Zacks

    Is McKesson (MCK) a Great Value Stock Right Now?

    Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

  • Reuters

    U.S. market sell-off brings short sellers $344 bln profit

    Investors betting on declines in U.S. stocks saw big profits in the last month as equities crashed while the global spread of coronavirus darkened economic prospects and net increases in short selling implying no turnaround in bearish sentiment. Short sellers borrow shares in the hope of buying them back at a cheaper price and pocketing the difference. U.S. shorts saw a one-month paper profit of $343.67 billion from the S&P 500 and Nasdaq's Feb. 19 peaks through to March 19, according to the latest data from financial technology and analytics firm S3 Partners, which measures bets against U.S. stocks and American Depository receipts.

  • 3 Top Defensive Plays for the Bear Market
    TipRanks

    3 Top Defensive Plays for the Bear Market

    We’re in a bear market now, with the major indexes down nearly 30% from their most recent peak. The S&P 500 has fallen from 3,386 – it’s high point on February 19 – down to 2,437 as of this writing. The fall hasn’t been smooth; stocks have bounced down a steep slope marked by sharp spike and deep troughs.So, the markets are stormy, and the bears are here, but a savvy stock trader should always remember what a bear does when the weather changes: it hunkers down, and hibernates for the long haul. It’s a defensive strategy, and investors should take the hint. Now is the time to pad the portfolio with defensive stocks, to soften the blow.What we’re looking for are stocks involved in essential goods and services – things that people need no matter how the markets perform. The stocks we’ll look at in this list fit that profile, one produces basic kitchen supplies, one offers digital cellular and mobile data services, and the third – particularly important in today’s conditions – produces pharmaceuticals and surgical supplies. As might be expected from stocks so uniquely suited to the current environment, all are Buy-rated and show an upside potential in excess of 15%. And one more bonus: each pays out a reliable dividend, providing an income stream for return-minded investors. We’ve run them through the TipRanks database, and pulled up the details. Let's dive in.Reynolds Consumer Products (REYN)Most of you will be familiar with Reynolds Consumer Products, simply because the company’s products are so ubiquitous. Aluminum foil and pans, plastic cling wrap and storage containers, oven cooking bags, even Hefty brand trash bags – all are products that most modern kitchens simply cannot do without. A necessary niche is a fine foundation for a defensive stock, and REYN has a solid one.Despite the good foundation, REYN pulled in lower Q4 revenue year-over-year, $835 million compared to $907 million the year before. Net income, however, was up by 7% to $90 million. In forward guidance, the company projects fiscal 2020 net income of $320 to $350 million.The company pays out a 15-cent quarterly dividend, which annualizes to 60 cents per share. The yield, at 2.3%, beats the average dividend yield among S&P-listed companies, and is nearly double the current yield of US Treasury bonds, making this stock a sound choice for income investors.Reviewing the stock for Credit Suisse, analyst Kaumil Gajrawala marks Reynolds as his "top defensive pick in an uncertain world." The analyst rates the stock a Buy, and sets a $34 price target that implies an upside of 24% from current levels. (To watch Gajrawala’s track record, click here)Supporting his view, Gajrawala writes, “Reynolds noted possible near-term benefits from inventory/pantry-loading and lower commodity costs, neither of which is reflected in guidance. Retailers are increasing orders given higher-than-normal consumer demand, shifting some volume near-term (and leading to increased usage). Also, recent declines in material prices, if sustainable, would have a positive impact on earnings going forward.”Overall, REYN shares get a Strong Buy rating from the analyst consensus, based on 9 reviews. The reviews include 7 Buys and 2 Holds. Shares are affordably priced, at $27.58, and the average target of $34.78 suggests room for a 26% upside potential in the next 12 months. (See Reynolds stock analysis on TipRanks)Verizon Communications (VZ)Next up is Verizon, a $225 billion market cap telecom giant, and the second largest wireless service provider in the US. Verizon boasts over 118 million wireless customers, and saw $132 billion in revenue for fiscal year 2019. This company is truly an 800-pound gorilla in the telecom industry.It’s also a very clear defensive play for investors. The coronavirus response is likely to increase the need for Verizon’s services, as authorities impose stricter ‘social distancing’ and quarantine restrictions on populations. Digital wireless services will be a convenient way for peers to remain in contact without violating those strictures.Still, VZ could have entered the current downturn in a stronger position than it did. The company’s Q4 earnings just missed the forecasts, despite a minor year-over-year gain. The $1.13 reported was just above the $1.12 year-ago number, and just below the $1.15 expectation. Revenues did better, and at $34.78 billion beat both the forecast and 2018’s Q4.Of the stocks on this list, Verizon offers the highest dividend yield, at 4.5%. The quarterly payment of 61.5 cents annualizes to $2.46, and the company has a 12-year history of maintaining reliable payouts. VZ has increased the dividend three times in the past three years, and the current payout ratio, of 54%, shows that the company has plenty of room for further increases.Colby Synesael, 5-star analyst with Cowen, upgraded his stance on VZ from Neutral to Buy, while maintaining his $61 price target. That target implies an upside potential of 16%. (To watch Synesael’s track record, click here)In support of his upgrade decision, Synesael wrote earlier this month, “[W]e look to take advantage of the recent sell-off with the stock now trading at a dividend spread not seen in 7+ years. We see low EPS risk considering its U.S.-centric utilitylike wireless business and a well-covered dividend currently yielding 4.5% with outer year catalysts tied to “true” 5G and building FCF.”Verizon’s Moderate Buy analyst consensus rating is founded on 12 reviews, including 5 Buy-side and 7 Holds. The stock is priced at $52.80, affordable for a true blue-chip giant, and its average price target of $63.22 indicates a 19% upside potential in the coming year. (See Verizon stock analysis on TipRanks)McKesson Corporation (MCK)With the last stock on our list, we turn to the pharma sector. Texas-based McKesson is a big name in medical technology, as big as its home state. The company provides software solutions for half of all US-based health systems, 25% of home care agencies, and 20% of all doctor practices. The company’s other main divisions are involved in medical supplies and equipment, and the 3,500-location Health Mart pharmacy chain. McKesson has its fingers – or really, its whole hand – in pretty much every part of the medical industry pie.McKesson’s huge presence in its field underlies its profitable position. The company’s fiscal 2020 Q3 earnings came in ahead of the estimates, with EPS beating the forecast by 7.6% at $3.54. Even more impressive, the EPS was up 12% year-over-year.The company managed that impressive earnings performance despite quarterly revenues coming in a half-percent under expectations. The $59.17 billion reported was up more than 5% yoy.On the dividend side, MCK is highly reliable. The company has been paying out quarterly dividends for 20 years, and has raised the payment three times in the last three years. The current dividend, 41 cents per quarter, or $1.64 annually, sounds small, and the yield is only 1.2%, but payout ratio is only 10%. For income investors, this dividend is as safe as they get – the company earnings are sound, the payment is easily affordable, and there is all sorts of room to raise the ceiling should management choose. Defensive-minded investors could not ask for a clearer bear-market play.This stock also received an upgrade recently, from 4-star analyst Glen Santangelo of Guggenheim. Santangelo’s $147 price target implies a modest upside of 8%, in cautious support of his newly raised Buy rating. (To watch Santangelo’s track record, click here)In his comments on the stock, Santangelo said, “We believe the recent underperformance of MCK shares vs. the market and supply chain peers has provided an attractive entry point for this defensive health care utility. As we have written for much of the past year, we believe the US distributors are operating against an improved fundamental backdrop - giving us confidence in the company's core execution. MCK has a strong FCF profile, boasting a ~14% FCF yield…” That FCF yield guarantees the company’s dividend.Like Verizon, this blue-chip stock has a Moderate Buy rating from the analyst consensus. The stock’s recent underperformance – noted by Santangelo – is reflected in the mix of 5 Buys, 4 Holds, and 1 Sell set in recent weeks. Shares are not cheap, priced at $129.11, but the average price target of $166.89 suggests room for 31% growth to the upside in the coming year. (See McKesson stock analysis on TipRanks)

  • MCK vs. COO: Which Stock Should Value Investors Buy Now?
    Zacks

    MCK vs. COO: Which Stock Should Value Investors Buy Now?

    MCK vs. COO: Which Stock Is the Better Value Option?

  • Is McKesson (MCK) Outperforming Other Medical Stocks This Year?
    Zacks

    Is McKesson (MCK) Outperforming Other Medical Stocks This Year?

    Is (MCK) Outperforming Other Medical Stocks This Year?

  • Reuters

    CORRECTED-From $1 bln Musk trial to jury duty being put on hold, coronavirus hits U.S. courts

    The coronavirus pandemic has begun to impact the U.S. court system, halting civil and criminal jury trials in high-profile venues such as Manhattan's federal court and delaying a $1 billion trial against Elon Musk that was slated to begin Monday. The postponements are raising questions about how courts will protect criminal defendants' rights to a speedy trial, clear a backlog of hundreds of thousands of asylum cases and resolve high-profile corporate disputes. "It's all happening at the speed of light," said Eric Tennen, a criminal defense lawyer in Massachusetts.

  • Fortune 500 company notifies state of layoffs at Memphis facility
    American City Business Journals

    Fortune 500 company notifies state of layoffs at Memphis facility

    One of Memphis' largest industrial warehouse employers filed a layoff notice with the State of Tennessee. McKesson Pharmaceutical Solutions & Services notified the Tennessee Department of Labor and Workforce Development of a “permanent closure” with an address listed as 4971 Southridge Blvd. in Memphis. A McKesson spokesperson said that Memphis is an important location for the company and that they will continue to invest in the area, citing an investment of nearly $20 million announced in November.

  • Implied Volatility Surging for McKesson (MCK) Stock Options
    Zacks

    Implied Volatility Surging for McKesson (MCK) Stock Options

    Investors need to pay close attention to McKesson (MCK) stock based on the movements in the options market lately.

  • Here is What Hedge Funds Think About McKesson Corporation (MCK)
    Insider Monkey

    Here is What Hedge Funds Think About McKesson Corporation (MCK)

    Coronavirus is probably the 1 concern in investors’ minds right now. It should be. On February 27th we publish an article with the title "Recession is Imminent: We Need A Travel Ban NOW". We predicted that a US recession is imminent and US stocks will go down by at least 20% in the next 3-6 […]

  • Reuters

    Closely watched opioid trial in New York postponed due to coronavirus

    A highly anticipated trial pitting New York state against McKesson Corp, Johnson & Johnson , CVS Health Corp and others for allegedly fueling the opioid epidemic has been postponed due to the coronavirus outbreak, according to the court. The postponement of the March 20 jury trial was a precautionary measure due to the number of people traveling to attend, according to a spokesman for New York Attorney General Letitia James. A new trial was not set but a hearing will be held April 14 to decide next steps in the case, which is in state court in Suffolk County on New York's Long Island.

  • Is McKesson (MCK) Stock Undervalued Right Now?
    Zacks

    Is McKesson (MCK) Stock Undervalued Right Now?

    Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

  • Why Is McKesson (MCK) Up 0.1% Since Last Earnings Report?
    Zacks

    Why Is McKesson (MCK) Up 0.1% Since Last Earnings Report?

    McKesson (MCK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • MCK or WST: Which Is the Better Value Stock Right Now?
    Zacks

    MCK or WST: Which Is the Better Value Stock Right Now?

    MCK vs. WST: Which Stock Is the Better Value Option?

  • Why McKesson (MCK) Could Be a Top Value Stock Pick
    Zacks

    Why McKesson (MCK) Could Be a Top Value Stock Pick

    McKesson (MCK) seems to be a good value pick, as it has decent revenue metrics to back up its earnings, and is seeing solid earnings estimate revisions as well.

  • Barrons.com

    Big Corporations Are Rushing Into Venture Capital. That May Not Be a Good Thing.

    Corporate capital is flooding in at a time when deal activity and valuations may be peaking. What investors need to know.

  • Zacks.com featured highlights include: McKesson, United Therapeutics, Virtusa and Cardinal Health
    Zacks

    Zacks.com featured highlights include: McKesson, United Therapeutics, Virtusa and Cardinal Health

    Zacks.com featured highlights include: McKesson, United Therapeutics, Virtusa and Cardinal Health

  • Reuters

    Opioid companies say lawyers' fee demand threatens settlement talks

    Johnson & Johnson and other drug companies facing thousands of lawsuits over their role in the opioid epidemic have warned that settlement talks will be "severely" jeopardized if plaintiffs' lawyers are allowed to assess a fee payment worth billions of dollars. Major distributors such as McKesson Corp and drugmakers including Teva Pharmaceutical Industries Ltd joined in the request that U.S. District Judge Dan Polster in Cleveland, Ohio, reject a request by a committee of plaintiffs' lawyers for a 7% fee assessed against any settlements. The request could amount to $3.3 billion, based on a $48 billion settlement proposal disclosed in October that five companies have been negotiating with various state attorneys general.

  • 4 Finest Value Stocks Based on Discounted PEG
    Zacks

    4 Finest Value Stocks Based on Discounted PEG

    A lower PEG ratio, preferably less than 1, indicates both undervaluation and solid future growth potential of a stock.